Altrenogest

CAS No. 850-52-2

Altrenogest( Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE )

Catalog No. M16177 CAS No. 850-52-2

Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 41 In Stock
100MG 58 In Stock
200MG 105 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Altrenogest
  • Note
    Research use only, not for human use.
  • Brief Description
    Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.
  • Description
    Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.(In Vitro):Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
  • In Vitro
    Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
  • In Vivo
    ——
  • Synonyms
    Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ER
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    850-52-2
  • Formula Weight
    310.43
  • Molecular Formula
    C21H26O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 2 mg/mL (6.44 mM); DMSO: 62 mg/mL (199.72 mM)
  • SMILES
    C[C@@]12[C@@](CC=C)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3C=C2)=O
  • Chemical Name
    (8S,13S,14S,17R)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Squires EL, et al. J Anim Sci, 1983, 56(4), 901-910.
molnova catalog
related products
  • Equol

    Equol ,a metabolite of soybeans, is an important isoflavone in humans,specifically binds to 5α-DHT, has a modest affinity for recombinant estrogen receptor ERβ. Phase 2.

  • GDC-0927 R-form

    GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).

  • Enclomiphene citrate

    Enclomiphene citrate((E)-Clomifene, cis-Clomifene, RMI-16289, ICI-46476)?is a nonsteroidal selective estrogen receptor modulator (SERM) that is under development for the treatment of male hypogonadism.